MoneyWorks4Me

Cipla informs about company updates

13 Apr 2016 Evaluate

With reference to earlier letters dated July 09, 2015, July 20, 2015, July 21, 2015, November 27, 2015, December 10, 2015, January 21, 2016, February 16, 2016 and March 01, 2016, Cipla has now informed that the Board of Directors of Cipla Health, a subsidiary of the Company, at their meeting held on April 12, 2016 allotted shares to FIL Capital Investments (Mauritius) II Limited and consequently, the transaction has now been completed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..